Longitudinal change in hyperpolarised 129-xenon MR spectroscopy in interstitial lung disease

J. Eaden (Sheffield, United Kingdom), P. Hughes (Sheffield, United Kingdom), G. Collier (Sheffield, United Kingdom), G. Norquay (Sheffield, United Kingdom), N. Weatherly (Sheffield, United Kingdom), M. Austin (Sheffield, United Kingdom), L. Smith (Sheffield, United Kingdom), J. Lithgow (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), S. Renshaw (Sheffield, United Kingdom), M. Buch (Leeds, United Kingdom), C. Leonard (Manchester, United Kingdom), S. Skeoch (Manchester, United Kingdom), N. Chaudhuri (Manchester, United Kingdom), G. Parker (Manchester, United Kingdom), S. Bianchi (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom)

Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019
Session: Imaging in respiratory disease: novel technologies in 2019
Session type: Thematic Poster
Number: 3158
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Eaden (Sheffield, United Kingdom), P. Hughes (Sheffield, United Kingdom), G. Collier (Sheffield, United Kingdom), G. Norquay (Sheffield, United Kingdom), N. Weatherly (Sheffield, United Kingdom), M. Austin (Sheffield, United Kingdom), L. Smith (Sheffield, United Kingdom), J. Lithgow (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), S. Renshaw (Sheffield, United Kingdom), M. Buch (Leeds, United Kingdom), C. Leonard (Manchester, United Kingdom), S. Skeoch (Manchester, United Kingdom), N. Chaudhuri (Manchester, United Kingdom), G. Parker (Manchester, United Kingdom), S. Bianchi (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom). Longitudinal change in hyperpolarised 129-xenon MR spectroscopy in interstitial lung disease. 3158

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Quantitative multivolume proton-magnetic resonance imaging in patients with cystic fibrosis lung disease: comparison with clinical indicators
Source: Eur Respir J, 53 (5) 1702020; 10.1183/13993003.02020-2017
Year: 2019



Gadofosveset-enhanced lung magnetic resonance imaging to detect ongoing vascular leak in pulmonary fibrosis
Source: Eur Respir J, 51 (5) 1800171; 10.1183/13993003.00171-2018
Year: 2018



Quantifying lung function in COPD with hyperpolarised 3He MRI
Source: Annual Congress 2012 - Functional imaging of the lung parenchyma, tumours and circulation
Year: 2012

Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial
Source: Eur Respir J 2009; 34: 1311-1321
Year: 2009



Multivolume magnetic resonance imaging (1H-MRI) for the longitudinal assessment of cystic fibrosis (CF) lung disease: comparison with spirometry
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




The study of proton magnetic resonance spectroscopy on hippocampus in rats with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011

Characterizing metabolic abnormality and adipose tissue infiltration in skeletal muscle of COPD patients using 31P MR spectroscopy and MRI imaging
Source: Annual Congress 2012 - The best abstracts in pulmonary rehabilitation
Year: 2012

Assessment of lung microstructure in ILD with 3He and 129Xe MRI
Source: International Congress 2015 – Functional imaging approaches for evaluating alteration of lung, airways and respiratory muscles
Year: 2015

Assessment of chest magnetic resonance imaging in non-cystic fibrosis chronic lung disease: comparison to high-resolution computed tomography and correlation with clinical and pulmonary function data
Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease
Year: 2009


Novel magnetic resonance technique for functional imaging of cystic fibrosis lung disease
Source: Eur Respir J, 50 (6) 1701464; 10.1183/13993003.01464-2017
Year: 2017



Evaluation of the peripheral airway microstructure in children with cystic fibrosis (CF) using 3He magnetic resonance imaging
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new therapies and detection of early lung disease
Year: 2012

Comparison of 1H MRI and 3He MRI ventilation images in patients with cystic fibrosis and patients with lung cancer
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018



Longitudinal monitoring of lung microstructure with HP gas diffusion-weighted MRI in mild cystic fibrosis children
Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Year: 2017



Hyperpolarised 129Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis
Source: Eur Respir J, 53 (5) 1802188; 10.1183/13993003.02188-2018
Year: 2019



1H and 129Xe MRI to detect functional and structural lung disease in sub-clinical cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



Patterns of regional lung physiology in cystic fibrosis using ventilation magnetic resonance imaging and multiple-breath washout
Source: Eur Respir J, 52 (5) 1800821; 10.1183/13993003.00821-2018
Year: 2018



Characterisation of acinar airspace involvement in patients with asthma using hyperpolarised 3He magnetic resonance and quantitative computed tomography
Source: International Congress 2014 – Functional imaging
Year: 2014

Non-contrast-enhanced assessment of lung perfusion in CF patients during respiratory tract exacerbation using Fourier decomposition magnetic resonance imaging (FDMRI)
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020

Regional hyperpolarised 129-xenon diffusion-weighted MRI in patients with IPF
Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease
Year: 2020